We are monitoring the impact of COVID-19 on APAC Genome Editing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2670
Share on
Share on

Asia Pacific Genome Editing Market Research Report - Segmented By Application, Technology, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 2670
Pages: 145

APAC Genome Editing Market Size (2020 to 2025)

The Genome Editing Market size in the Asia Pacific was worth USD 0.71 billion in 2020 and estimated to be growing at a CAGR of 15.66% to reach USD 1.47 billion by 2025 during the forecast period.

Genome editing is a branch of genetic engineering in which DNA is inserted, deleted, or replaced in the genome of a living organism with the aid of engineered nucleases, which are otherwise known as molecular scissors. They work by creating site-specific double-strand breaks at the desired locations in the genome.

Genome Editing is used for research to understand the biology and inner workings of cells, to treat diseases such as modifying human blood cells to treat conditions such as leukemia and AIDS. Other applications include in the field of biotechnology, where it is used to modify crops to increase their yield and their resistance to diseases and drought. Another new application is genetically modifying cattle to develop them without horns.

The significant factors affecting the Asia-Pacific Genome Editing market include technological advancements concerning the development of novel vectors used in genome editing and rising competition among operating companies to get a larger market share. Another driver for the market is the emerging interest in genome editing by pharmaceutical and biotechnological companies.

Despite this, the toxicity due to off-target effects of nucleases is still a safety concern for the market. Additionally, the IP disputes related to the use of CRISPR technology amongst the industry players are also expected to act as restraints for the market.

This research report has been segmented and sub-segmented into the following categories:

  • By Application: Cell Line, Animal Genetic and Plant Genetic Engineering
  • By Technology: CRISPR, TALEN, ZFN, Antisense, and Other Technologies
  • By End-User: Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes, and Contract Research Organizations
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regionally, the Chinese genome editing market is projected to have fast growth in this region over the review period, followed by Japan, India, and other countries. The growth of China is attributed due to factors such as advanced technologies in developing new novel drugs for genome editing, growing elder people population, and changing lifestyle, which may lead to chronic disorders of this APAC region is likely to accelerate the market growth. In April 2016, Japan invested nearly USD 76million for the next five years for the creation of Japanese owned genome editing technologies over the analysis period.

Few of the top companies leading the Asia Pacific Genome Editing Market profiled in the report are Thermo Fisher Scientific, Merck KGAA, Horizon Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences, Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

  1. Research Methodology

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                             

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

  1. Market Segmentation

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Cell Line Engineering           

                                5.1.3 Animal Genetic Engineering            

                                5.1.4 Plant Genetic Engineering

                                5.1.5 Y-o-Y Growth Analysis, By Application         

                                5.1.6 Market Attractiveness Analysis, By Application       

                                5.1.7 Market Share Analysis, By Application        

                5.2 Technology                 

                                5.3.1 Introduction           

                                5.3.2 CRISPR      

                                5.3.3 TALEN       

                                5.3.4 ZFN            

                                5.3.5 Antisense

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8 Market Attractiveness Analysis, By Technology      

                                5.3.9 Market Share Analysis, By Technology        

                5.3 End User                      

                                5.2.1 Introduction           

                                5.2.2 Biotechnological & Pharmaceutical Companies       

                                5.2.3 Academic and Government Research Institutes     

                                5.2.4 Contract Research Organizations   

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

  1. Geographical Analysis

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Technology

                                                6.1.3.4 By End User

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Technology

                                                6.1.4.4 By End User

                                6.1.5 Market Share Analysis       

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Technology

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

  1. Strategic Analysis

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five Analysis                             

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

  1. Market Leaders' Analysis

                8.1 Thermo Fisher Scientific                        

                                8.1.1 Overview 

                                8.1.2 Application Analysis            

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck KGAA                              

                8.3 Horizon Discovery Group Plc                               

                8.4 Genscript Biotech Corporation                           

                8.5 Sangamo Biosciences                             

                8.6 Integrated DNA Technologies                            

                8.7 Lonza Group Ltd                       

                8.8 New England Biolabs                              

                8.9 Origene Technologies                            

                8.10 Transposagen Biopharmaceuticals                 

  1. Competitive Landscape

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

  1. Market Outlook and Investment Opportunities

Appendix                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia Pacific Genome Editing Market Market By Application, From 2020 to 2025 (USD Billion)
  2. Asia Pacific Cell Line Engineering Market By Region, From 2020 to 2025 (USD Billion)
  3. Asia Pacific Animal Genetic Engineering Market By Region, From 2020 to 2025 (USD Billion)
  4. Asia Pacific Plant Genetic Engineering Market By Region, From 2020 to 2025 (USD Billion)
  5. Asia Pacific Genome Editing Market Market By Technology, From 2020 to 2025 (USD Billion)
  6. Asia Pacific CRISPR Market By Region, From 2020 to 2025 (USD Billion)
  7. Asia Pacific TALEN Market By Region, From 2020 to 2025 (USD Billion)
  8. Asia Pacific ZFN Market By Region, From 2020 to 2025 (USD Billion)
  9. Asia Pacific Antisense Market By Region, From 2020 to 2025 (USD Billion)
  10. Asia Pacific Other Technologies Market By Region, From 2020 to 2025 (USD Billion)
  11. Asia Pacific Genome Editing Market Market By End User, From 2020 to 2025 (USD Billion)
  12. Asia Pacific Biotechnological & Pharmaceutical Companies Market By Region, From 2020 to 2025 (USD Billion)
  13. Asia Pacific Academic and Government Research Institutes Market By Region, From 2020 to 2025 (USD Billion)
  14. Asia Pacific Contract Research Organizations Market By Region, From 2020 to 2025 (USD Billion)
  15. Japan Genome Editing Market Market By Application, From 2020 to 2025 (USD Billion)
  16. Japan Genome Editing Market Market By Technology, From 2020 to 2025 (USD Billion)
  17. Japan Genome Editing Market Market By End User, From 2020 to 2025 (USD Billion)
  18. China Genome Editing Market Market By Application, From 2020 to 2025 (USD Billion)
  19. China Genome Editing Market Market By Technology, From 2020 to 2025 (USD Billion)
  20. China Genome Editing Market Market By End User, From 2020 to 2025 (USD Billion)
  21. India Genome Editing Market Market By Application, From 2020 to 2025 (USD Billion)
  22. India Genome Editing Market Market By Technology, From 2020 to 2025 (USD Billion)
  23. India Genome Editing Market Market By End User, From 2020 to 2025 (USD Billion)
  24. Australia Genome Editing Market Market By Application, From 2020 to 2025 (USD Billion)
  25. Australia Genome Editing Market Market By Technology, From 2020 to 2025 (USD Billion)
  26. Australia Genome Editing Market Market By End User, From 2020 to 2025 (USD Billion)
  27. South Korea Genome Editing Market Market By Application, From 2020 to 2025 (USD Billion)
  28. South Korea Genome Editing Market Market By Technology, From 2020 to 2025 (USD Billion)
  29. South Korea Genome Editing Market Market By End User, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample